AIP
HQL

Ahrens Investment Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Ahrens Investment Partners’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-600
Closed -$12K – 1067
2021
Q4 		$12K Buy
+600
New +$12.1K 0.01% 704

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Ahrens Investment Partners's HQL Position: Q1 2022 in Review

Ahrens Investment Partners sold out of abrdn Life Sciences Investors (HQL) in Q1 2022, closing a stake of 600 shares — an estimated $12K sold.

Ahrens Investment Partners first reported a position in HQL in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 66 funds tracked by Wall St. Rank hold HQL as of Q1 2022.

  • Ahrens Investment Partners reported no remaining abrdn Life Sciences Investors position as of Q1 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 600 abrdn Life Sciences Investors shares in Q1 2022, an estimated $12K.
  • Ahrens Investment Partners first reported a position in abrdn Life Sciences Investors in Q4 2021 and held it in 1 quarter.
  • Ahrens Investment Partners's abrdn Life Sciences Investors position peaked at $12K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2022.

Based on Ahrens Investment Partners's 13F filing for Q1 2022, filed 28 Apr 2022.